Elsevier

The Lancet

Volume 338, Issues 8782–8783, 28 December 1991, Pages 1550-1554
The Lancet

Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathway

https://doi.org/10.1016/0140-6736(91)92373-AGet rights and content

Abstract

Long-term deficiency of cobalamin or folate causes a demyelinating disease of the brain and spinal cord. A reduced supply of methyl groups has been implicated as its cause. To examine the mechanisms of demyelination in human beings, we have studied three children with sequential inborn errors of the methyl-transfer pathway. One child had abnormal methylfolate metabolism, one abnormal methylcobalamin metabolism, and one hypermethioninaemia probably caused by methionine adenosyltransferase deficiency. Magnetic resonance imaging of the brain and measurement of cerebrospinal-fluid concentrations of 5-methyltetrahydrofolate, methionine, and S-adenosylmethionine were carried out before and after 6-12 months of appropriate treatment. Each patient had abnormal myelination before treatment; the scans suggested demyelination. The only consistent biochemical abnormality in the cerebrospinal fluid was a low concentration of S-adenosylmethionine. Treatment led to substantial clinical improvement, apparent remyelination, and increases in cerebrospinal-fluid S-adenosylmethionine concentration into the normal range. Cerebrospinal-fluid concentrations of S-adenosylmethionine and methionine were significantly lower in eight other children with errors of the methyl-transfer pathway than in an age-matched reference population (mean [95% confidence interval] standard deviation score -1·81 [0·57], p<0·001 for S-adenosyl methionine and -1·82 [0·19], p<0·001 for methionine). The concentrations of these metabolites increased to within the reference range on treatment. We have shown that demyelination is associated with cerebrospinal-fluid S-adenosylmethionine deficiency and that restoration of S-adenosylmethionine is associated with remyelination.

References (31)

  • Jsr Russell et al.

    Subacute combined degeneration of the spinal cord

    Brain

    (1900)
  • Rd Adams et al.

    Subacute combined degeneration of the brain in pernicious anemia

    N Engl J Med

    (1944)
  • Pt Clayton et al.

    Subacute combined degeneration of the spinal cord, dementia and parkinsonism due to an inborn error of folate metabolism

    J Neurol Neurosurg Psychiatry

    (1986)
  • R. Carmel et al.

    Hereditary defect of cobalamin metabolism (cbl G mutation) presenting as a neurological disorder in adulthood

    N Engl J Med

    (1983)
  • Mj Mahoney et al.

    Recent advances in the inherited methylmalmonic acidaemias

    Acta Pediatr Scand

    (1987)
  • Cited by (217)

    • Mini-review: Aplastic myelin following chemotherapy

      2022, Neuroscience Letters
      Citation Excerpt :

      The availability of raw materials can become a limiting factor in the process of myelination. As an example, folic acid is necessary for synthesis of both nucleic acids and methionine, the latter being essential for myelination [106]. Methotrexate (MTX)-based chemotherapy acts by depleting folic acid.

    View all citing articles on Scopus
    View full text